1. Home
  2. ETR vs TAK Comparison

ETR vs TAK Comparison

Compare ETR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entergy Corporation

ETR

Entergy Corporation

HOLD

Current Price

$96.38

Market Cap

42.2B

Sector

Utilities

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$16.16

Market Cap

43.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETR
TAK
Founded
1949
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.2B
43.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ETR
TAK
Price
$96.38
$16.16
Analyst Decision
Buy
Analyst Count
18
0
Target Price
$101.88
N/A
AVG Volume (30 Days)
2.2M
2.6M
Earning Date
02-17-2026
01-29-2026
Dividend Yield
2.65%
3.27%
EPS Growth
N/A
N/A
EPS
4.07
0.14
Revenue
$12,730,047,000.00
$29,846,840,032.00
Revenue This Year
$9.89
N/A
Revenue Next Year
$7.43
$0.47
P/E Ratio
$23.71
$226.88
Revenue Growth
7.32
N/A
52 Week Low
$75.55
$12.80
52 Week High
$98.58
$16.48

Technical Indicators

Market Signals
Indicator
ETR
TAK
Relative Strength Index (RSI) 62.68 63.86
Support Level $92.81 $15.87
Resistance Level $93.99 $16.48
Average True Range (ATR) 1.56 0.19
MACD 0.48 0.01
Stochastic Oscillator 90.59 66.00

Price Performance

Historical Comparison
ETR
TAK

About ETR Entergy Corporation

Entergy is a holding company with five regulated vertically integrated utilities that generate and distribute electricity to 3 million customers in Arkansas, Louisiana, Mississippi, and Texas. It is one of the largest power producers in the country with 27 gigawatts of rate-regulated owned and leased power generation capacity. Entergy was the second-largest nuclear owner in the US before it began retiring and selling its plants in the Northeast in 2014. It sold its two small gas utilities in Louisiana in 2025.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: